Skip to main content
Fig. 2 | Diabetology & Metabolic Syndrome

Fig. 2

From: 2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes

Fig. 2

Steatotic liver disease (SLD) subclassification. This figure depicts the schema for SLD and its subcategories. Within the MetALD group, there was a continuum across which the contributions of MASLD and ALD varied. To align with the current literature, limits have been set accordingly for weekly and daily consumption, as the impact of varying levels of alcohol intake varies between individuals. *Weekly intake 140–350 g female, 210–420 g male (average daily intake of 20–50 g female, 30–60 g male). **e.g., lysosomal acid lipase deficiency (LALD), Wilson disease, hypobetalipoproteinaemia, inborn errors of metabolism. ***e.g., hepatitis C virus (HCV), malnutrition, celiac disease, human immunodeficiency virus (HIV). Adapted from Rinella et al. [15]

Back to article page